Canine Diabetes Wiki
Huminsulin Normal
R, Neutral by Eli Lilly
U40, U100 none
Action in dogs:
  • onset 10-30 minutes,
  • peak 1-5h,
  • duration 4-10h [1]
Line: Humulin
Also known as: Humulin C, Humulin RHumuline R, Humulin Regular, Humulina Regular
Humuline Regular, Humulin SHumulin ReliOn R, Umuline Rapide, Umuline Regular
Similar to: Insuman Rapid, Winthrop Rapid
Actrapid, Novolin R, ReliOn/Novolin R

Names of Lilly r-DNA/GE/GM insulins worldwide
Use and Handling:
Shelf Life: 24 months Type: soluble, clear
When Opened: 28 days room temp.
In Pen: 28 days room temp.
Notes: Protect from light and heat
Do Not Freeze,
May be used intravenously

Human activity profile for r-DNA/GE/GM R (Regular)/Neutral insulin. See links for dog activity.

Note that some countries have the brand name in U40 strength.

Huminsulin Normal is one of several brands of "Regular" or "neutral" (short-acting) insulin, used for a quick consumption of blood sugar with little delay. It's known in North America as Humulin R. [2][3]

It consists of zinc insulin crystals dissolved in clear fluid with no additives to alter its action or speed. [2]

Other brands with the same action profile include:

A short-acting, soluble, non-suspended insulin produced from r-DNA/GE/GM, bovine, or porcine sources. From 1921 to the 1930's when PZI was developed, R was the only kind of insulin available.

While both R/neutral and semilente insulins are considered fast-acting, they differ in a few ways. As above, there's no suspension or buffer. [13] in R/neutral; it's totally dissolved and soluble, meaning it can safely be used intravenously. [14]

The very small insulin particles in semilente insulin are suspended by zinc. [13] Semilente is cloudy, has an acetate buffer and cannot be used intravenously.

R/Neutral insulin cannot be reliably mixed with Lente or Ultralente insulins. [15][16] Semilente can; the ratio of 3 parts semilente insulin to 7 parts ultralente insulin produces Lente insulin. [13]

R/Neutral Insulins[]


  1. Insulins. North American Veterinary Conference Clinicians Brief (2006).
  2. 2.0 2.1 Humulin R patient leaflet. Eli Lilly.
  3. Humulin R Regular Human Insulin. Revolution Health.
  4. Novolin R Regular Human Insulin. Eli Lilly.
  5. Patient Information Leaflet-Humulin S. Eli Lilly.
  6. Humulin S Prescribing Information.
  7. Lilly EU/UK Product Sheet & Time Activity Profiles. Eli Lilly.
  8. Patient Information Leaflet-Actrapid. Novo Nordisk.
  9. Scientific Discussion-Actrapid. EMEA.
  10. Prescribing Novo Insulins.
  11. Patient Information Leaflet-Insuman Rapid. Sanofi-Aventis.
  12. Prescribing Insuman Insulins.
  13. 13.0 13.1 13.2 DeRuiter, Jack. Insulin Preparations-Regular Insulin. Auburn University. Cite error: Invalid <ref> tag; name "Auburn" defined multiple times with different content Cite error: Invalid <ref> tag; name "Auburn" defined multiple times with different content
  14. Maddison, Jill E.,Page, Stephen W.,Church, David B. (2008). Small Animal Clinical Pharmacology. Saunders Ltd..
  15. Deckert, T. (1980). Intermediate-Acting Insulin Preparations: NPH (Isophane) & Lente. Diabetes Care.
    Note--in 1980, there were no r-DNA/GE/GM insulins
  16. Resource Guide. American Diabetes Association (2005).

More Information[]

Related Pages
A1833110 HumilinLILLY 21944f DSC02818 Actrapid
Novolin R
Humulin R
Humulin S
Insuman Rapid